Royal Bank Of Canada Novan, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.41 - $1.4 $702 - $2,398	1,713 Added 1713.0%	1,813 $0
Q4 2022 Feb 14, 2023	SELL	$0.82 - $1.48 $93 - $168	-114 Reduced 53.27%	100 $0
Q3 2022 Nov 14, 2022	BUY	$1.76 - $3.03 $128 - $221	73 Added 51.77%	214 $0
Q2 2022 Aug 15, 2022	BUY	$2.29 - $3.86 $322 - $544	141 New	141 $0
Q3 2021 Nov 15, 2021	SELL	$7.48 - $10.17 $396 - $539	-53 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$7.8 - $17.35 $413 - $919	53 New	53 $1,000

Ticker NOVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,281,600
Market Cap $638K
Description
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.